Informations pratiques
Adresse

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France

Standard

Tel : +33 (0)1 42 11 42 11

Urgences

Gustave Roussy n'assure que les urgences des patients pris en charge à l'Institut.
Urgences uniquement : +33 (0)1 42 11 50 00

GUSTAVE ROUSSY
1er centre de lutte contre le cancer en Europe, 3 000 professionnels mobilisés

Etudes et Recherche en Economie de la Santé

Responsable
Julia Bonastre

Contact
Tél. :+33 (0)1 42 11 62 77

Frise de présentation (bandeau): 
Etudes et Recherche en Economie de la Santé

Publications Etudes et Recherche en Economie de la Santé 2019

  1. Bourgain C, Pourtau L, Mazouni C, Bungener M, Bonastre J. Imperfect biomarkers for adjuvant chemotherapy in early stage breast cancer with good prognosis. Social Science & Medicine 2020; Volume 246, doi 112735.
  2. Foulon S, Cony-Makhoul P, Guerci-Bresler A, Delord M, Solary E, Monnereau A,Bonastre J, Tubert-Bitter P. Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study. Cancer Med. 2019 Jun;8(6):3296-3304.
  3. Bayle A, Besse B, Annereau M, Bonastre J. Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact? Eur J Cancer. 2019 May;113:28-31.
  4. Lafuma A, Cotté FE, Le Tourneau C, Emery C, Gaudin AF, Torreton E, Gourmelen J, Bonastre J. Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries. J Med Econ. 2019 Jul;22(7):698-705.
  5. Balleyguier C, Dunant A, Ceugnart L, Kandel M, Chauvet MP, Chérel P, Mazouni C, Henrot P, Rauch P, Chopier J, Zilberman S, Doutriaux-Dumoulin I, Jaffre I,Jalaguier A, Houvenaeghel G, Guérin N, Callonnec F, Chapellier C, Raoust I,Mathieu MC, Rimareix F, Bonastre J, Garbay JR. Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS. J Clin Oncol. 2019 Apr 10;37(11):885-892.
  6. Kandel M, Dalle S, Bardet A, Allayous C, Mortier L, Dutriaux C, Guillot B,Leccia MT, Dalac S, Legoupil D, Saiag P, Montaudie H, Arnault JP, Brunet-Possenti F, Grob JJ, DeQuatrebarbes J, Beylot-Barry M, Lesimple T, Aubin F, Maubec E,Granel-Brocard F, Stoebner PE, Dupuy A, Dreno B, Michiels S, Lebbe C, Borget I. Quality-of-life assessment in French patients with metastatic melanoma in real life. Cancer. 2019 Oct 22.
  7. Lacas B, Bouché O, Etienne PL, Gasmi M, Texereau P, Gargot D, Lombard-Bohas C, Azzedine A, Denis B, Geoffroy P, Auby D, Michel P, Pignon JP, Lepage C, Ducreux M, Borget I. Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial. Expert Rev Pharmacoecon Outcomes Res. 2019 Oct;19(5):601-608.
  8. Bathily T, Borget I, Rivin Del Campo E, Rivera S, Bourgier C., Partial versus whole breast irradiation: Side effects, patient satisfaction and costs, Cancer Radiother. 2019 Apr;23(2):83-91.

Publications Etudes et Recherche en Economie de la Santé 2014-18

PDF icon> Liste des publications Etudes et Recherche en Economie de la Santé 2014-2018 (document PDF)

Catégorie de la page: